Cargando…
Severe Cholestatic Hepatitis Secondary to SARS-CoV-2
Liver injury is a common manifestation of coronavirus disease 2019 (COVID-19), with most injuries manifesting as transient mild hepatocellular injury. Cholestatic injury occurs less commonly and is typically mild. Severe cholestatic injury is rare, with only 4 cases reported in the literature. We pr...
Autores principales: | Lindholm, Christopher R., Zhang, Xiaofei, Spengler, Erin K., Daniel, Kimberly E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963841/ https://www.ncbi.nlm.nih.gov/pubmed/35359752 http://dx.doi.org/10.14309/crj.0000000000000753 |
Ejemplares similares
-
Su322 SEVERE CHOLESTATIC HEPATITIS SECONDARY TO SARS-COV-2
por: Lindholm, Christopher R., et al.
Publicado: (2021) -
Cholestatic Hepatitis and Thrombocytosis in a Secondary Syphilis Patient
por: Kim, Gi Hyun, et al.
Publicado: (2010) -
Tozinameran: Severe cholestatic hepatitis: case report
Publicado: (2021) -
Azithromycin-induced cholestatic hepatitis
por: Koffas, Apostolos, et al.
Publicado: (2017) -
SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease
por: Duengelhoef, Paul, et al.
Publicado: (2022)